No Data
BioNTech SE ADR Falls Monday, Underperforms Market
Why Is BioNTech SE (BNTX) Among the Best High Growth Healthcare Stocks to Invest In Now?
Morgan Stanley Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $145
BioNTech SE (BNTX) Receives a Buy From Morgan Stanley
BMO Capital Maintains BioNTech(BNTX.US) With Buy Rating, Maintains Target Price $126
Promising Oncology Developments and Stable COVID-19 Business Drive BioNTech SE's Buy Rating